Krystal Biotech, Inc. (Nasdaq: KRYS) (the “Company”), a gene therapy company dedicated to developing and commercializing novel treatments for patients ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Equity Offerings

Krystal Biotech (KRYS) Prices 3M Share Offering at $20/ShOctober 19, 2018 5:36 AM Krystal Biotech Announces Commencement of $60.0 Million Public Offering of Common StockOctober 17, 2018 4:00 PM